Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Airway diseases and inflammatory bowel diseases: is it something in the air (pollution)?

Jeremy A. Hirota, Chris Carlsten, Mohsen Sadatsafavi, Gilaad Kaplan, Simon A. Hirota
European Respiratory Journal 2015 46: 287-288; DOI: 10.1183/09031936.00003815
Jeremy A. Hirota
1Division of Respiratory Medicine, Dept of Medicine, Gordon and Leslie Diamond Health Care Centre, Vancouver, BC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jhirota@mail.ubc.ca
Chris Carlsten
1Division of Respiratory Medicine, Dept of Medicine, Gordon and Leslie Diamond Health Care Centre, Vancouver, BC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohsen Sadatsafavi
1Division of Respiratory Medicine, Dept of Medicine, Gordon and Leslie Diamond Health Care Centre, Vancouver, BC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gilaad Kaplan
2Snyder Institute for Chronic Diseases and Institute of Public Health, Depts of Medicine and Community Health Sciences, Calgary, AB, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simon A. Hirota
3Dept of Physiology and Pharmacology, Dept of Immunology, Microbiology and Infectious Diseases, Health Sciences Centre, Calgary, AB, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

A discussion of the environmental factors influencing lung and gut disease: is it something in the air? http://ow.ly/MW86M

To the Editor:

Our group has recently discussed the exciting European Respiratory Journal publication by Brassard et al. [1] that shows an increased incidence of the inflammatory bowel diseases (IBD) in subjects with airway disease. In this population-based cohort study, the incidence of Crohn's disease was higher in the asthma (by 27%) and chronic obstructive pulmonary disease (COPD) (by 55%) groups relative to the general population. This study complements other recent observations showing increased gut permeability in those with COPD relative to healthy controls [2], which is a potential mechanism for development of IBD. Taken together, these data suggest a common link in the pathogenesis of IBD and airway disease; however, the mechanisms responsible for these interesting observations remain unclear.

Brassard et al. [1] present a balanced critique of their findings, suggesting that validation of the findings through other administrative datasets in additional regions would increase the generalisability of the findings. Although we agree that additional epidemiological studies validating data in other jurisdictions is important, exploring the mechanisms responsible for their observations through basic and translational science should also be emphasised. The authors highlight potential mechanisms relevant to their observations in the discussion, focusing on a potential role for cigarette smoke exposure. Their comments are well warranted, as cigarette smoke is an established environmental risk factor for airway disease and a disease modifier in IBD (deleterious in Crohn's disease; protective in ulcerative colitis) [3]. Unfortunately, due to the limitations of the administrative dataset, they were unable to obtain information about cigarette smoking history and other factors (e.g. shared genetic susceptibility) that may have been able to inform potential mechanisms behind their observations.

Air pollution is another important inhaled environmental factor that can contribute to both airway [4] and gut disease [5]. Inhaled air pollution can deposit directly into the lungs or be swept up the mucociliary ladder to be ingested into the gastrointestinal tract. In the lung, particulate air pollution can promote inflammatory cell recruitment [6], while in the gut it can exacerbate intestinal inflammation in experimental models of IBD and induce changes in the intestinal microbiome [7]. The mechanisms responsible for these observations may converge on common innate immune pathways at these mucosal sites [8]. In a mouse model of air pollution exposure to the lungs, we have previously demonstrated the involvement of the nucleotide-binding domain and leucine-rich repeat protein 3 (NLRP3) inflammasome in the initiation of an innate immune response in the airways [6], while in the gut, we have shown that the NLRP3 inflammasome is a key player in innate immunity and helps to maintain intestinal mucosal homeostasis through regulation of the intestinal microbiome [9]. Understanding how air pollution exposure modulates innate immune signalling in these two organs may yield new insight into the pathogenesis of both airway diseases and IBD.

To extend the epidemiological work of Brassard et al. [1] and others investigating the impact of air pollution on lung and gut health, complementary experimental approaches should be performed to explore the biological plausibility of epidemiological findings. These approaches should include in vitro cell culture experiments [6], in vivo animal experiments [6, 9] and controlled human exposure models to air pollution such as diesel exhaust [10]. By combining epidemiology with basic and translational experimental approaches, observations made at a population level can be explored mechanistically.

In closing, we applaud the work of Brassard et al. [1] for bringing attention to the link between airway disease and IBD. If their findings are validated in another cohort and extended with mechanistic experimental evidence, there will be increasing need to appreciate how environmental exposures, including air pollution, influence lung and gut health. Tightly linking air pollution exposure, airway disease and IBD could inform individual preventive measures and disease management, and further justify air quality controls.

Footnotes

  • Conflict of interest: None declared.

  • Received January 10, 2015.
  • Accepted January 25, 2015.
  • Copyright ©ERS 2015

References

  1. ↵
    1. Brassard P,
    2. Vutcovici M,
    3. Ernst P, et al.
    Increased incidence of inflammatory bowel disease in Quebec residents with airway diseases. Eur Respir J 2015; 45: 962–968.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Rutten EP,
    2. Lenaerts K,
    3. Buurman WA, et al.
    Disturbed intestinal integrity in patients with COPD: effects of activities of daily living. Chest 2014; 145: 245–252.
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    1. Tobin MV,
    2. Logan RF,
    3. Langman MJ, et al.
    Cigarette smoking and inflammatory bowel disease. Gastroenterology 1987; 93: 316–321.
    OpenUrlPubMedWeb of Science
  4. ↵
    1. Sava F,
    2. Carlsten C
    . Respiratory health effects of ambient air pollution: an update. Clin Chest Med 2012; 33: 759–769.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Kaplan GG,
    2. Hubbard J,
    3. Korzenik J, et al.
    The inflammatory bowel diseases and ambient air pollution: a novel association. Am J Gastroenterol 2010; 105: 2412–2419.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Hirota JA,
    2. Hirota SA,
    3. Warner SM, et al.
    The airway epithelium nucleotide-binding domain and leucine-rich repeat protein 3 inflammasome is activated by urban particulate matter. J Allergy Clin Immunol 2012; 129: 1116–1125.
    OpenUrlCrossRefPubMedWeb of Science
  7. ↵
    1. Kish L,
    2. Hotte N,
    3. Kaplan GG, et al.
    Environmental particulate matter induces murine intestinal inflammatory responses and alters the gut microbiome. PLoS One 2013; 8: e62220.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Keely S,
    2. Talley NJ,
    3. Hansbro PM
    . Pulmonary-intestinal cross-talk in mucosal inflammatory disease. Mucosal Immunol 2012; 5: 7–18.
    OpenUrlCrossRefPubMedWeb of Science
  9. ↵
    1. Hirota SA,
    2. Ng J,
    3. Lueng A, et al.
    NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis. Inflamm Bowel Dis 2011; 17: 1359–1372.
    OpenUrlCrossRefPubMedWeb of Science
  10. ↵
    1. Birger N,
    2. Gould T,
    3. Stewart J, et al.
    The Air Pollution Exposure Laboratory (APEL) for controlled human exposure to diesel exhaust and other inhalants: characterization and comparison to existing facilities. Inhal Toxicol 2011; 23: 219–225.
    OpenUrlCrossRefPubMed
View Abstract
PreviousNext
Back to top
View this article with LENS
Vol 46 Issue 1 Table of Contents
European Respiratory Journal: 46 (1)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Airway diseases and inflammatory bowel diseases: is it something in the air (pollution)?
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Airway diseases and inflammatory bowel diseases: is it something in the air (pollution)?
Jeremy A. Hirota, Chris Carlsten, Mohsen Sadatsafavi, Gilaad Kaplan, Simon A. Hirota
European Respiratory Journal Jul 2015, 46 (1) 287-288; DOI: 10.1183/09031936.00003815

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Airway diseases and inflammatory bowel diseases: is it something in the air (pollution)?
Jeremy A. Hirota, Chris Carlsten, Mohsen Sadatsafavi, Gilaad Kaplan, Simon A. Hirota
European Respiratory Journal Jul 2015, 46 (1) 287-288; DOI: 10.1183/09031936.00003815
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Footnotes
    • References
  • Info & Metrics
  • PDF

Subjects

  • Epidemiology, occupational and environmental lung disease
  • COPD and smoking
  • Asthma and allergy
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Agora

  • Refined risk stratification in PAH and timing of lung transplantation
  • Outcomes of cirrhotic patients with pre-capillary pulmonary hypertension
  • Diagnosis for cystic fibrosis with new generation sweat test
Show more Agora

Correspondence

  • Refined risk stratification in PAH and timing of lung transplantation
  • COVID-19 drug research and the cohort multiple randomised controlled trial design
  • COVID-19 drug research and the cohort multiple randomised controlled trial design
Show more Correspondence

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2022 by the European Respiratory Society